SwePub - search: WFRF:(Khandekar Rajiv)

Enumeration	Reference	Cover	Find
1.	Harbi, Majed Al, et al. (author) Association between sickle cell trait and the prevalence and severity of diabetic retinopathy 2016 In: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 11:7 Journal article (peer-reviewed)abstract Purpose To determine whether Sickle cell trait (SCT) is associated with an increased severity of diabetic retinopathy. Methods This was a single center retrospective study case control study of 100 eyes of 100 patients with diabetes mellitus (DM) with SCT (SCT group) and 100 eyes of 100 age-matched patients with DM without SCT (control group). The main outcome measure was the difference in the prevalence of sight threatening DR [here defined as diabetic macular edema (DME) and/or proliferative diabetic retinopathy (PDR)], between the SCT and control groups. Secondary outcome measures included differences in visual acuity, ocular comorbidities, intraocular pressure, glycemic control as assessed by random blood glucose measurement, diabetes duration, nephropathy, hyperlipidemia and hypertension. Results The SCT group had statistically significantly shorter duration of DM (median [25% quartile] 15 [8.3] years versus 20 [14.7] years, respectively)(P

Harbi, Majed Al, et al. (author)
Association between sickle cell trait and the prevalence and severity of diabetic retinopathy
2016
In: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 11:7
Journal article (peer-reviewed)abstract
- Purpose To determine whether Sickle cell trait (SCT) is associated with an increased severity of diabetic retinopathy. Methods This was a single center retrospective study case control study of 100 eyes of 100 patients with diabetes mellitus (DM) with SCT (SCT group) and 100 eyes of 100 age-matched patients with DM without SCT (control group). The main outcome measure was the difference in the prevalence of sight threatening DR [here defined as diabetic macular edema (DME) and/or proliferative diabetic retinopathy (PDR)], between the SCT and control groups. Secondary outcome measures included differences in visual acuity, ocular comorbidities, intraocular pressure, glycemic control as assessed by random blood glucose measurement, diabetes duration, nephropathy, hyperlipidemia and hypertension. Results The SCT group had statistically significantly shorter duration of DM (median [25% quartile] 15 [8.3] years versus 20 [14.7] years, respectively)(P

Träfflista för sökning "WFRF:(Khandekar Rajiv) srt2:(2016)"